Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Societ\ue0 Italiana di Medicina Interna) Study

Authors
Publication date
1 January 2017
Publisher
'Springer Science and Business Media LLC'
Doi

    Abstract

    Older patients are prone to multimorbidity and polypharmacy, with an inherent risk of adverse events and drug interactions. To the best of our knowledge, available information on the appropriateness of lipid-lowering treatment is extremely limited

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Archivio della ricerca - Università degli studi di Napoli Federico II

      redirect
      oaioai:www.iris.unina.it:11588/81...
      Last time updated on 10/09/2020

      Catalogo dei prodotti della ricerca

      redirect
      oaioai:iris.univr.it:11562/962433
      Last time updated on 09/07/2019